SHUKRA PHARMACEUTICALS
Back to Balance Sheet
|
SHUKRA PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹17 Cr | ₹14 Cr | ₹43 Cr | ₹12 Cr | ₹7.04 Cr |
What is the latest Total Current Liabilities ratio of SHUKRA PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹17 Cr |
| Mar2024 | ₹14 Cr |
| Mar2023 | ₹43 Cr |
| Mar2022 | ₹12 Cr |
| Mar2021 | ₹7.04 Cr |
How is Total Current Liabilities of SHUKRA PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹17 Cr | 22.12 | |
| Mar2024 | ₹14 Cr | -66.70 | |
| Mar2023 | ₹43 Cr | 243.46 | |
| Mar2022 | ₹12 Cr | 75.92 | |
| Mar2021 | ₹7.04 Cr | - | |
Compare Total Current Liabilities of peers of SHUKRA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHUKRA PHARMACEUTICALS | ₹2,115.1 Cr | -0.8% | -22.3% | 159.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,773.0 Cr | -6.8% | -7.6% | -4.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,540.0 Cr | -6.6% | -5.8% | 4.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,529.0 Cr | 0.9% | 5.7% | 27.3% | Stock Analytics | |
| CIPLA | ₹111,299.0 Cr | -4.8% | -8.1% | -3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,393.0 Cr | -2% | -8.8% | -12.9% | Stock Analytics | |
SHUKRA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHUKRA PHARMACEUTICALS | -0.8% |
-22.3% |
159.9% |
| SENSEX | -2% |
-2.8% |
7.4% |
You may also like the below Video Courses